Medical University Of South Carolina

This study tested a vaccine called PROSTVAC-V/F in men who had surgery for prostate cancer and were at high risk of the cancer returning. The goal was to see if the vaccine could keep cancer from coming back. The trial was stopped early, so results are limited, but it aimed to im…

This study looked at whether a drug called OPC could lower AGE levels in men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). AGEs are substances that can build up in the body and may cause health problems. The study planned to enroll 41 part…

This study looked at whether a 24-hour infusion of octreotide works as well as a 72-hour infusion to prevent early rebleeding in people with cirrhosis who had bleeding esophageal varices treated with endoscopic banding. The trial enrolled 34 adults with known or suspected cirrhos…

This study tested a cold atmospheric plasma device on children aged 4-21 with warts or molluscum lesions. The goal was to see if the treatment could safely clear the lesions over up to a year of monthly sessions. The trial was terminated early, so results are limited.

This study tested a combination of two drugs, tarloxotinib and sotorasib, in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. Participants had already tried other treatments, including a KRAS-targeting drug, but their cancer con…

This study looked at whether istradefylline, a drug already approved for motor symptoms in Parkinson's disease, could also help with apathy—a common problem where people lose interest and motivation. The study planned to track changes in physical activity and engagement over 12 w…

This study looked at whether having a certified therapy dog present during a dental injection helps reduce anxiety and improve behavior in children aged 3 to 7. Researchers compared kids who had a dog in the room to those who did not, measuring heart rate, oxygen levels, and beha…

This study tested whether the sleep medication suvorexant (20 mg) could help breast cancer survivors who have trouble sleeping. Five postmenopausal women who had finished cancer treatment and were taking hormone therapy were enrolled. The trial was stopped early, so results are l…